3D Global Biotech Inc. demonstrated significant market volatility this week, closing at 65.20 TWD on January 3, representing a 7.25% decline from the previous day’s close of 70.30 TWD.
The stock traded within a wide 5-day range of 55.60 TWD to 73.50 TWD, coming close to its 52-week high of 73.50 TWD and far above its 52-week low of 18.80 TWD.
Trading activity was notably intense, with a total weekly volume of 6,254,719 shares, starkly contrasting the average volume of 812,183 shares. The company’s market capitalization stood at 5.008 billion TWD, underscoring its position in the biotechnology sector.
Despite the increased activity, 3D Global Biotech’s financial metrics remain a concern. The company is currently operating at a loss with a negative earnings per share (EPS) of -0.52 TWD and no available price-to-earnings (PE) ratio.
Disclaimer: This summary is based solely on the provided data and is not intended as investment advice.